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Lipid-bilayer coated nanosized bimodal mesoporous
carbon spheres for controlled release applications†
Benjamin Mandlmeier,‡ Stefan Niedermayer,‡ Alexandra Schmidt, Jörg Schuster
and Thomas Bein*
Highly mesoporous nanosized carbon spheres (MCS) equipped with an active lipid bilayer demonstrate
pronounced molecular release behavior, and excellent potential for drug delivery applications. We report
a facile synthesis route for the creation of colloidal MCS with a bimodal pore size distribution, featuring
a high BET surface area combined with high pore volume. Bimodal mesoporosity was achieved by a
simultaneous co-assembly of a polymer resin (resol), tetraethyl orthosilicate (TEOS) and a block
copolymer (Pluronic F127). The spherical geometry originates from casting the precursor mixture into a
macroporous silica hard template, having a mean pore size of 60 nm, followed by thermopolymerization
and final carbonization at 900 1C in nitrogen atmosphere. The final bimodal mesoporous MCS were
obtained after removal of inorganic compounds by etching with hydrofluoric acid. Colloidal suspensions
of MCS were prepared by oxidation with ammonium persulfate. MCS were loaded with calcein as a
model drug. Efficient sealing of the MCS was achieved with a supported lipid bilayer (SLB). The SLB acts
as a diffusion barrier against the uncontrolled release of encapsulated dye molecules until the release is
triggered via the addition of a surface active agent. The high surface area and pore volume and the
excellent release characteristics make the SLB-coated MCS a promising release-on-demand system.
Introduction
Colloidal mesoporous carbon particles feature several properties
that make them attractive candidates for controlled release and
possibly drug delivery applications. These properties include
high surface areas and pore volumes resulting in high loading
capacities and good dispersibility. Additionally, carbon can be
equipped with various chemical functionalities, which are often
required to create more complex systems. Up to now, important
systems explored in targeted drug delivery are based on meso-
porous silica,1–3 liposomes,4,5 protein-based nanocarriers6 and
polymers.7–10 Different porous carbon morphologies, such as
activated carbon particles,11,12 carbon nanotubes (CNTs)12–16
and ordered mesoporous carbon (CMK-3),17 loaded with certain
compounds and exhibiting good biocompatibility18,19 have been
reported in the context of drug delivery. Combining magnetic
properties with carbon nanostructures is also being discussed
for medical applications.20 Nevertheless, certain carbon nano-
materials such as multi-walled CNT, carbon fibers and certain
types of particles (carbon black) can lead to cytotoxic effects
depending on their size, aspect ratio and surface chemistry.21
Another study showed that functionalization of CNTs reduced
toxic effects to the cytosol.22 Several reports describe the for-
mation of mesoporous carbon for drug delivery by replicating
silica hard templates. Zhu et al. showed the functionalization of
mesoporous carbon with a thermo-responsive polymer.17 Based
on this work, spherical mesoporous carbon in the size range of
500–800 nm was recently prepared, exhibiting a BET surface area
of 1069 m2 g1 and high pore volume of 1.49 cc g1, with a pore
diameter of 6.0 nm.22 Many approaches for the preparation of
mesoporous carbons are known,23 and the morphology can be
controlled by the dimensions of hard templates. For example,
MCM-48 silica particles were used as template for ordered
mesoporous carbon (CMK-1).24 Furthermore, mesoporous carbon
nanoparticles (MCNs) providing a high BET surface area of
2034 m2 g1 and a pore volume of 1.2 cc g1 were applied in
drug delivery experiments.25 Hydrophilic amino-functionalized
MCNs in the range of 100 to 150 nm were also obtained, and
their high drug storage capacity was attributed to a BET surface
area of 1309 m2 g1 and a pore volume of 0.9 cc g1 (with small
pores below 3 nm).26 High biocompatibility was shown for
mesoporous carbon nanoparticles hydrothermally derived from
resol as carbon source and the block-copolymer Pluronic
F127.19 With this approach, particle sizes ranging from ca. 20
to 140 nm were obtained, but the highest BET surface area
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of 1131 m2 g1 was accompanied by a small pore size of 2.6 nm
for 90 nm large particles. The influence of the particle size on
endocytosis was demonstrated with MCNs having small diameters
of around 90 nm.27 These samples were prepared by a hydrothermal
route, using the block co-polymer Pluronic F127 as soft-template,
resulting in particles with a BET surface area of 746 m2 g1, a pore
volume of 0.76 cc g1, and a pore size of 2.7 nm.
A novel general route for ordered mesoporous carbon (OMC)
with high porosity involves a concerted co-assembly of carbon
and silica precursors with Pluronic F127 and successive tem-
plate removal after full carbonization, providing a bimodal pore
size distribution.28 Based on this method, we recently reported
the synthesis of dispersible and porous carbon spheres (sized
about 330 nm) using macroporous silica as hard template.29
Those MCNs provided the highest inner pore volumes for
mesoporous carbon nanoparticles of 2.32 cc g1 and also one
of the highest surface areas of 2445 m2 g1 with a bimodal pore
size distribution of large and small mesopores of 6 nm and
3.1 nm. The above-mentioned properties make these particles
attractive candidates for drug delivery applications.
Here we report the synthesis of very small mesoporous
carbon nanospheres with extremely high porosity and present
the first efficient cap system for colloidal mesoporous carbon
nanospheres (Fig. 1).
We synthesized very small mesoporous carbon nanospheres
with diameters ranging from 45 to 70 nm using a macroporous
silica hard template providing appropriate dimensions. Our
particles feature a very high BET surface area of 2003 m2 g1
and a high pore volume of 1.95 cc g1. To the best of our
knowledge, this is the highest specific pore volume for mesoporous
carbon nanoparticles at a size below 100 nm and also one of the
highest surface areas. Additionally, a bimodal porosity with
maxima at 5.9 and 3.1 nm was achieved by removal of F127
from the pores and silica from the walls. In this study we
combine an extremely high loading capacity and very suitable
particle sizes for improved cell uptake. The use of supported
lipid bilayers (SLBs) as cap systems has been successfully
demonstrated for mesoporous silica nanoparticles.29–35 Being a
very simple imitation of a cell membrane, SLBs can enhance
circulation times and accumulation in tumor tissue as reported
for the delivery of doxorubicin.36 Compared to liposomes, the solid
nanoparticle core offers two major advantages. First, narrow size
distributions and second, enhanced stability in comparison with
liposomes can be achieved.32,33,37,38 Based on these attractive
features, we transferred the concept of SLBs to mesoporous carbon
and present the first efficient cap system for colloidal mesoporous
carbon nanospheres. Efficient sealing of the mesopores could be
achieved by coating each carbon sphere with an SLB. Regarding the
lipid formulation, we used a mixture of cationic and neutral lipids
(DOTAP and DOPC) and 60 nm MCS. To demonstrate the effective-
ness of our cap-system, the triggered release of calcein was studied
in vitro by fluorescence spectroscopy.
Experimental section
Materials
Sodium dodecyl sulfate, potassium persulfate, ammonium
persulfate, methyl methacrylate (99%), tetraethyl orthosilicate
(technical grade), concentrated HCl (37% in water), sodium
hydroxide, Pluronic F127, calcein, Triton X-100, sulfuric acid
and organic solvents were obtained from Aldrich and used
without further purification. Formalin (37 wt% formaldehyde
in water) and phenol was purchased from Merck KGaA and
Pluronic F127 from BASF AG. Used lipids: DOPC (1,2-dioleoyl-
sn-glycero-3-phosphocholine, Avanti Polar Lipids), DOTAP (1,2-
dioleoyl-3-trimethylammonium-propane, Avanti Polar Lipids).
Synthesis of PMMA spheres
PMMA spheres of about 60 nm were prepared by a modified
route reported elsewhere.39 The emulsion polymerization was
started by adding a solution of 227.2 mg potassium persulfate
(K2S2O8, 0.84 mmol) in 2 mL water to a mixture of 27.56 g
methyl methacrylate (MMA, 275.3 mmol), 196 mg sodium
dodecyl sulfate (SDS, 0.68 mmol) in 98 mL water at 70 1C. The
water was degassed by flushing with nitrogen for 1 h, before SDS
and MMA were added and the mixture was then stirred under
refluxing conditions for 1 h at 70 1C. After 2 h of polymerization
the reaction was stopped by external cooling and applying air to
the three-neck round bottom flask (250 mL). The resulting
colloidal solution was washed three times with water by centri-
fugation at 20 500 rpm (50 228 rcf) for 30 min. This solution was
dried in plastic petri dishes for several days and the resulting
flakes of several mm in size were dried at 80 1C for 2 h.
Synthesis of macroporous silica
For the synthesis of the macroporous silica the obtained PMMA
flakes were collected on a filter paper and cast multiple times
with a hydrolyzed silica precursor solution. The residual solution
was removed by applying vacuum to the Büchner funnel. For the
silica solution, 12 mL tetraethyl orthosilicate (TEOS, 53.8 mmol)
were added to 8 mL ethanol under stirring. To the clear solution
6 mL water and 1 mL concentrated hydrochloric acid (HCl, 37%)
were dropped and stirred for another 10 min at room tempera-
ture.29 Finally, the PMMA/SiOx composite was calcined in air at
550 1C for 5 h (ramp: 1 1C min1).
Synthesis of mesoporous carbon spheres
For this purpose, a mixture of resol precursor as carbon source
and silica precursor were used for casting the previously
Fig. 1 Surfactant induced release of calcein (green) from mesoporous
carbon nanoparticles encapsulated by a supported lipid bilayer.
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prepared macroporous silica template. The resol precursor was
prepared according to Meng et al.40 Here, 21 g formalin (37 wt%
formaldehyde in water, 0.259 mol) was added dropwise at 50 1C
to a solution of 12.2 g phenol (0.128 mol) and 2.6 g of 20 wt%
sodium hydroxide solution (0.013 mol). The final solution was
then heated for 1 h at 75 1C and cooled to room temperature.
After neutralizing the basic solution using hydrochloric acid
(1 M), water was removed by rotary evaporation. The resulting
product was diluted in absolute ethanol to achieve a solution of
20 wt% (resol precursor).
For the final casting solution, 2.0 g of Pluronic F127, 20.0 g
of ethanol, and 2.0 g of 0.2 M HCl were mixed well at 40 1C.
Then, 4.16 g TEOS and 5.0 g of the 20 wt% resol solution were
added.28 The resulting yellow solution was stirred for another
5 h at the same temperature. Typically, 10 g of the solution were
cast on 100 mg of the macroporous silica template, and the
evaporation of the solvents and self-assembly of the F127
occurred at room temperature in an open Petri dish during
2–3 days. The resulting and filled flakes were collected and
thermopolymerized in air at 100 1C for 24 h, followed by
carbonization at 900 1C in a stream of nitrogen. Here, the material
was heated first to 350 1C (rate: 1 1C min1; dwell time: 3 h), then to
600 1C (rate: 1 1C min1) and finally to 900 1C (rate: 5 1C min1;
dwell time: 2 h). The resulting shiny black bulk material was
additionally treated with aqueous hydrofluoric acid (10 wt%),
usually 100 mg solid material in 20 mL solution, for 2 days, to
remove silica from the macroporous template and from the walls
of the mesoporous carbon phase. This treatment was followed by
filtration and threefold washing with water (MilliporeQ) and
absolute ethanol.
Oxidation of nanosized mesoporous carbon spheres
To obtain a colloidal suspension of carbon spheres, the bulk
material was oxidized in a mixture of ammonium persulfate
and sulfuric acid.41 Specifically, 30 mg MCS were added to a
mixture of 2.4 g ammonium persulfate in 4 mL sulfuric acid
(1 M). The resulting suspension was stirred for 24 h at room
temperature. Subsequently, the particles were washed 5 times
by centrifugation (14 000 rpm, 16 873 rcf, 8 min) and redispersion
in 5 mL MilliporeQ water.
Preparation of SLB@MCS loaded with calcein
The amount of 1 mg oxidized colloidal mesoporous carbon was
dispersed in 500 mL of an aqueous solution of calcein (1 mM) and
stirred (500 rpm) for 2 h at room temperature in the dark. After
centrifugation (14 000 rpm, 16 873 rcf, 8 min), 100 mL of a premixed
lipid solution (70 mL DOPC + 30 mL DOTAP, each 2.5 mg mL1 in a
mixture of 40 vol% EtOH/60 vol% water) were added. Upon
addition of 700 mL of MilliporeQ water, the formation of a
supported lipid bilayer on the external surface of MCS was induced.
The SLB@MCS were then centrifuged and redispersed in 800 mL
MilliporeQ water, to eliminate unsupported lipids and ethanol.
In vitro release experiment
The amount of 200 mL of the aqueous suspension (pH = 7.2)
containing SLB@MCS loaded with calcein was transferred into
a tube which could be closed with a dialysis membrane (with a
molecular-weight cutoff of 16 000 g mol1).42 This custom
made cap fits on the opening of a fluorescence cuvette, filled
with MilliporeQ water (pH = 7.2). Only the fluorescent molecules
are able to diffuse through the dialysis membrane, whereas the
MCS material stays entrapped in the cap and is not able to enter
the cuvette, where the dye molecules are detected by fluores-
cence spectroscopy. For the delivery experiment, a time-based
measurement with an excitation wavelength of 495 nm and an
emission wavelength of 517 nm was recorded. The dye-loaded
sample was monitored in the closed state up to 4 h, showing no
significant release of the dye molecules. After the addition of
5 mL Triton X-100 (1 : 1000 v/v in H2O) into the tube containing
the SLB@MCS, the removal of the lipids from the MCS allowed
for the diffusion of calcein out of the pores through the dialysis
membrane and their detection in the cuvette. The release in the
open state was monitored for an additional 3 h.
Characterization
Scanning electron microscopy (SEM) was performed on a JEOL
JSM-6500F operating at 3–5 kV (field emission).
Transmission electron microscopy (TEM) images were obtained
with an FEI Titan 80–300 equipped with a field-emission gun
(300 kV) using the high-angle annular dark-field mode (STEM-
HAADF).
Dynamic light scattering (DLS) of aqueous solutions was
recorded on a Malvern Zetasizer-Nano equipped with a 4 mW
He–Ne laser (633 nm) and avalanche photodiode detector.
Nitrogen sorption measurements were performed on a
NOVA 4000e at 196 1C (Quantachrome) after outgassing the
sample at 120 1C under vacuum. A QSDFT model of N2 on
carbon (slit/cylindr./sphere pores, adsorption branch) was used
to calculate the pore volume, and the surface area was calculated
with the BET model (p/p0 = 0.05–0.20).
Small-angle X-ray scattering was performed on a Bruker D8
Discover (Cu-Ka1 = 1.5406 Å, theta-theta geometry).
IR spectra were recorded on a Bruker Equinox 55 FT-IR,
using KBr pellets.
Fluorescence spectra were recorded on a PTI spectrofluo-
rometer with a photomultiplier detection system (model 810/
814). The 1 cm quartz cuvette (QG Hellma) was placed in a
cuvette holder with magnetic stirring.
UV-Vis spectra were recorded on a NanoDrop ND-2000 with
1 mL samples.
Results and discussion
Three-dimensionally ordered macroporous (3DOM) silica, which
was further used as hard template, was prepared by replicating
an array of close-packed PMMA spheres. PMMA spheres were
prepared by emulsion polymerization. The washed particles were
dried in petri dishes at room temperature to obtain millimeter
sized bulk material. Fig. 2a represents an SEM image of an
ordered domain of packed PMMA spheres with diameters of
around 75–80 nm. These PMMA templates were collected, and
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cast several times with a pre-hydrolyzed TEOS precursor solution, to
achieve a complete filling of the interstitial voids. The resulting
PMMA/SiOx composite was dried for several hours and calcined at
550 1C to solidify the silica precursor and to remove the PMMA
template. The resulting pore diameter ranges from about 60–70 nm,
which is smaller than the initial size of the PMMA spheres,
attributed to heating-induced shrinkage.43,44 The bulk material
shows good accessibility of the pores through random interpore
connections in the range of about 20 nm. A rough silica surface was
attributed to the loose initial packing of the PMMA spheres. The
random orientation is also indicated by a diffuse ring, obtained by
the Fourier Transform (FFT, inset) of the rectangular area (white).
The diffuse ring indicates a d-spacing of around 70 nm, which is
slightly smaller than the lattice spacings of the PMMA template
(Fig. 2b).
This macroporous silica was further used as hard template
for the synthesis of bimodal mesoporous carbon spheres. As
carbon source we used resol, which was co-assembled with two
porogen compounds, TEOS and Pluronic F127. This precursor
mixture enables a homogeneous dispersion of TEOS within the
walls of the carbon mesostructure during an evaporation-
induced self-assembly (EISA), occurring during the casting
and drying of the precursor within the empty voids of the
macroporous silica hard template. Subsequent thermopolymer-
ization at 100 1C for 24 h and carbonization at 900 1C in
nitrogen results in full carbonization and conversion of TEOS
into silica, which is dispersed in the walls of the mesoporous
network. Simultaneously the total removal of Pluronic F127 is
responsible for mesopore formation. All silica residues were
successfully etched with hydrofluoric acid (10 wt%), which
creates a loose packing of nanosized mesoporous carbon
particles (MCS) in the range of 45 to 68 nm (Fig. 2c). The
particles can be separated either by oxidation with ammonium
persulfate or ultrasound treatment, leading to well-dispersed
colloidal suspensions (Fig. 2d, photograph). The DLS measure-
ment shows a maximum size of 59 nm, which is consistent with
the SEM data.
The obtained MCS were also characterized by STEM-HAADF
(Fig. 3a and b), demonstrating their uniform particle size. The
very small carbon spheres feature a rough surface with accessible
mesopores and smaller ones that are present in the walls. The
pore structure seems to be ordered and regarding the small-
angle X-ray scattering data (Fig. S1, ESI†) a d-spacing of around
8.8 nm for the MCS was found. The broad reflection is attributed
to a relatively small confined size within this macroporous
template. In contrast, we previously found a pronounced highly
ordered hexagonal phase within carbon spheres having dia-
meters of around 330 nm.29 From nitrogen sorption measure-
ments (Fig. 3c) a type IV isotherm was obtained, showing a wide
hysteresis and no defined saturation at high relative pressures.
We attribute this to textural porosity between the particles.
A high BET surface area of 2003 m2 g1 and a high total pore
volume of 1.95 cc g1 was achieved.
The bimodal porosity, resulting from the removal of F127
and silica from the walls, exhibits two maxima at 5.9 nm and
3.1 nm, respectively. Taken together, the above properties
suggest that these small mesoporous particles are attractive
candidates for introducing chemical functionality and for
applications as potential drug delivery system. For the creation
of a SLB@MCS system, the hydrophobic particle surface had to
be oxidized. Here we used a procedure known in the literature.41
The successful oxidation of MCS in a solution of ammonium
persulfate in sulfuric acid is shown by IR spectroscopy (Fig. 4).
The emerging peaks (at 1725, 1618, 1385, 1210 and 1030 cm1),
can be attributed to carbonyl (carboxylic acid, keto-groups, and
esters) and hydroxyl groups formed during the oxidation process
Fig. 2 SEM images of (a) the PMMA colloidal crystal template before
TEOS impregnation, (b) the corresponding randomly ordered (FFT inset)
macroporous silica replicate after calcination at 550 1C (inset: a 2D fast
Fourier transform (FFT) of the white square) and (c) bimodal mesoporous
carbon spheres after carbonization at 900 1C in nitrogen and final removal
of silica residues by HF treatment. (d) DLS and photograph (inset) depict a
homogeneous size distribution of the spheres in solution.
Fig. 3 (a and b) STEM-HAADF images of MCS at different magnifications,
obtained after HF treatment. Nitrogen sorption measurements reveal a
type IV isotherm (c) and a bimodal pore size distribution (d).
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(black curve). This oxidized surface is expected to be negatively
charged at neutral pH, thus enhancing interactions with the
positively charged head groups of the phospholipids and facilitating
the formation of an SLB around the MCS. In addition to the above-
mentioned benefits, DOPC features a double bond in the chain, and
hence this lipid offers the possibility to enable a triggered release
with so-called photosensitizers that generate reactive oxygen species
upon light activation.45–47
To show the potential of SLB@MCS as a release-on-demand
system, we demonstrate that the SLB is able to prevent the
premature release of dye molecules from the mesostructure at
body temperature (37 1C).
For this purpose, we loaded a fluorescent dye (calcein) as a
model for drug molecules into the mesopores of MCS and
capped the nanospheres with a lipid bilayer containing DOPC
and DOTAP (Fig. S2, ESI†). Afterwards, the calcein-loaded
SLB@MCS were transferred into a tube sealed with a dialysis
membrane (Fig. 5a) and mounted on top of a fluorescence
cuvette filled with water (pH = 7.2). The membrane only allows
the dye molecules to diffuse into the cuvette, whereas the MCS
stay entrapped in the tube. As long as the cap system blocks the
release of the dye, no fluorescence signal can be detected
(Fig. 5b).31,42 In this experiment, even after 4 h, no significant
release was observed. Only after rupture of the SLB through the
addition of the surfactant Triton X-100, dye molecules were able
to diffuse out of the bimodal porous carbon particles across the
membrane into the cuvette. The entire amount of calcein was
released within 3 h (Fig. S3, ESI†). The amount of 121 mg calcein
per mg MCS illustrates the high loading capacity of these highly
porous carbon spheres (Fig. S4, ESI†).
Conclusions
We present a strategy for the synthesis of 60 nm large and
colloidal nanosized carbon spheres (MCS). Their bimodal porosity
features a high BET surface area as well as a high pore volume,
which makes them attractive candidates for drug delivery agents
with high loading capacity. The synthesis is based on the
replication of small macroporous silica hard templates, by
concerted co-assembly of a mixture of resol, TEOS and Pluronic
F127. After successive thermopolymerization, carbonization and
silica removal, the bimodal mesoporous carbon spheres can be
separated into colloidal MCS by oxidative treatment. The meso-
porous nanoparticles were loaded from solution with fluorescent
calcein as model drug and efficiently sealed with a stable
supported lipid bilayer (SLB) cap system. Molecular release
experiments demonstrate the effective closure and release of
this system, providing a tight seal until the addition of Triton
X-100, which destabilizes the lipid bilayer and initiates a complete
and triggered release of the fluorescent dye from the highly porous
carbon. Therefore, our results show the ability of SLB@MCS as
effective cap system around colloidal mesoporous carbon nano-
particles with enhanced loading capacities for triggered release
applications.
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Fig. 4 Infrared spectroscopy of as synthesized (red) and oxidized MCS
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Fig. 5 (a) Schematic presentation and photo of the release setup.31,42
(b) Release profile of calcein in SLB@MCS at 37 1C.
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FFT Fast Fourier transform
MCS Nanosized mesoporous carbon spheres
HAADF High-angle annular dark-field
PMMA Poly(methyl methacrylate)
SLB Supported lipid bilayer
STEM Scanning transmission electron microscope
TEOS Tetraethyl orthosilicate.
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